Anna-Kaisa Ruotsalainen
Postdoctoral Researcher
Postdoctoral researcher
A.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences
Novel genetic atherosclerosis risk factors and future therapeutic targets in CVD.
Research groups
Publications
18/18 items-
Deletion of the Murine Ortholog of the Human 9p21.3 Locus Leads to Insulin Resistance and Obesity in Hypercholesterolemic Mice
Kettunen, Sanna; Suoranta, Tuisku; Beikverdi, Sadegh; Heikkilä, Minja; Slita, Anna; Räty, Iida; Ylä-Herttuala, Elias; Öörni, Katariina; Ruotsalainen, Anna-Kaisa; Ylä-Herttuala, Seppo. 2024. Cells. 13: A1 Journal article (refereed), original research -
Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity
Kettunen, Sanna; Ruotsalainen, Anna-Kaisa; Örd, Tiit; Suoranta, Tuisku; Heikkilä, Janne; Kaikkonen, Minna U.; Laham-Karam, Nihay; Ylä-Herttuala, Seppo. 2023. Frontiers in cardiovascular medicine. 10: . 1113890 A1 Journal article (refereed), original research -
Genetic variation is a key determinant of chromatin accessibility and drives differences in the regulatory landscape of C57BL/6J and 129S1/SvImJ mice
Mononen, Juho; Taipale, Mari; Malinen, Marjo; Velidendla, Bharadwaja; Niskanen, Einari; Levonen, Anna-Liisa; Ruotsalainen, Anna-Kaisa; Heikkinen, Sami. 2023. Nucleic acids research. 2024; 52: 2904-2923 A1 Journal article (refereed), original research -
Western Diet Decreases Hepatic Drug Metabolism in Male LDLr−/−ApoB100/100 Mice
Koponen, Markus; Rysä, Jaana; Ruotsalainen, Anna-Kaisa; Kärkkäinen, Olli; Juvonen, Risto O. 2023. Journal of nutrition and metabolism. 2023: A1 Journal article (refereed), original research -
RNA interference-based therapies for the control of atherosclerosis risk factors
Kettunen, Sanna; Ruotsalainen, Anna-Kaisa; Ylä-Herttuala, Seppo. 2022. Current opinion in cardiology. 37: 364-371 A2 Review article, Literature review, Systematic review -
Menaquinone 4 increases plasma lipid levels in hypercholesterolemic mice
Weisell, Jonna; Ruotsalainen, Anna-Kaisa; Näpänkangas, Juha; Jauhiainen, Matti; Rysä, Jaana. 2021. Scientific reports. 11: 3014 A1 Journal article (refereed), original research -
Novel RNAi-Based Therapies for Atherosclerosis
Ruotsalainen, Anna-Kaisa; Mäkinen, Petri; Ylä-Herttuala, Seppo. 2021. Current atherosclerosis reports. 23: 45 A2 Review article, Literature review, Systematic review -
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice
Gurzeler, Erika; Ruotsalainen, Anna-Kaisa; Laine, Anssi; Valkama, Teemu; Kettunen, Sanna; Laakso, Markku; Ylä-Herttuala, Seppo. 2021. PLoS ONE. 16: e025840 A1 Journal article (refereed), original research -
LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight from Mouse Models
Cedo, Lidia; Metso, Jari; Santos, David; García-León, Annabel; Plana, Nuria; Sabate-Soler, Sonia; Rotllan, Noemi; Rivas-Urbina, Andrea; Mendez-Lara, Karen A; Tondo, Mireia; Girona, Josefa; Julve, Josep; Pallarès, Victor; Benitez-Amado, Aleyda; Llorente Cortes, Vicenta; Pérez, Antonio; Gómez-Coronado, Diego; Ruotsalainen, Anna-Kaisa; Levonen, Anna-Liisa; Sanchez-Quesada, Jose Luis et al.. 2020. Circulation research. 127: 778-792 A1 Journal article (refereed), original research -
Nucleic Acid-Based Therapies for Atherosclerosis
Mäkinen, P; Ruotsalainen, AK; Ylä-Herttuala, S. 2020. Current atherosclerosis reports. 22: 10 A2 Review article, Literature review, Systematic review